from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0852/fadD16

LFCtreatmentdescriptionclass of inhibitor

-0.006

Amikacinug/mL Amikacintranslation

-0.156

Cap5-10ug/mL Capreomycintranslation

0.799

Rox10-50 ug/mL Roxithromycintranslation

-0.186

SM2-5 ug/mL Streptomycintranslation

1.697

Tet5-10 ug/mL Tetracyclinetranslation

0.525

Rif0.2-5ug/mL Rifampicintranscription

0.239

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.571

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.147

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.064

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.263

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.952

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.345

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.254

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.000

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

3.108

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.176

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.580

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.155

Nigericin50 uM Nigericinrespiration

-0.100

TRC10-150 ug/mL Triclosanrespiration

-1.346

TRZ10-25 ug/mL Thioridazinerespiration

0.100

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.164

menadione6-10 ug/mL Menadionerespiration

-0.786

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.219

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.187

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.260

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.218

NRP_1Non-replicating persistence stage 1dosRassociated

-0.380

Amp0.2mg/mL AmpicillincellWall

-0.334

Cephalexin20-100 ug/mL CephalexincellWall

-0.252

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.169

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.222

EMB10-20 ug/mL EthambutolcellWall

-0.093

Eta12-40 ug/mL EthionamidecellWall

0.274

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.260

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.621

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.517

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.204

BZA0.12 mg/mL BenzamidearomaticAmides

0.725

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.653

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.262

H2O24 mM hydrogen peroxideDNAdamaging

0.378

Levo10 ug/mL LevofloxacinDNAdamaging

0.304

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.612

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.013

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.106

UVUV-irradiationDNAdamaging

0.260

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.457

Antimycin12.5-50 ug/mL Antimycin A?

-0.353

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.159

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.190

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.066

PA8240.2-2 ug/mL PA-824?

-0.220

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.117

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.449

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.146

methoxatin10-20 ug/mL Methoxatin?